Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 2
1999 1
2004 2
2006 2
2007 2
2008 3
2009 2
2010 1
2011 4
2012 8
2013 3
2015 6
2017 4
2018 3
2019 1
2020 2
2022 1
2023 4
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Dendritic cell-based vaccine efficacy: aiming for hot spots.
Pizzurro GA, Barrio MM. Pizzurro GA, et al. Among authors: barrio mm. Front Immunol. 2015 Mar 3;6:91. doi: 10.3389/fimmu.2015.00091. eCollection 2015. Front Immunol. 2015. PMID: 25784913 Free PMC article. Review.
Lessons from cancer immunoediting in cutaneous melanoma.
Aris M, Barrio MM, Mordoh J. Aris M, et al. Among authors: barrio mm. Clin Dev Immunol. 2012;2012:192719. doi: 10.1155/2012/192719. Epub 2012 Aug 14. Clin Dev Immunol. 2012. PMID: 22924051 Free PMC article. Review.
Editorial: "Cancer Immunotherapy: Lights and Shadows".
Barrio MM, Levy EM, Mordoh J. Barrio MM, et al. Front Immunol. 2015 Jul 7;6:350. doi: 10.3389/fimmu.2015.00350. eCollection 2015. Front Immunol. 2015. PMID: 26217342 Free PMC article. No abstract available.
HEV-associated dendritic cells are observed in metastatic tumor-draining lymph nodes of cutaneous melanoma patients with longer distant metastasis-free survival after adjuvant immunotherapy.
Bravo AI, Aris M, Panouillot M, Porto M, Dieu-Nosjean MC, Teillaud JL, Barrio MM, Mordoh J. Bravo AI, et al. Among authors: barrio mm. Front Immunol. 2023 Aug 25;14:1231734. doi: 10.3389/fimmu.2023.1231734. eCollection 2023. Front Immunol. 2023. PMID: 37691949 Free PMC article.
A Th2-score in the tumor microenvironment as a predictive biomarker of response to Bacillus Calmette Guérin in patients with non-muscle invasive bladder carcinoma: A retrospective study.
Villoldo GM, Pombo MT, Aris M, Chemi J, Mandó P, Nagaraju S, Camean J, Burioni A, Egea D, Amat M, Mellado JL, Mordoh J, Villaronga A, Barrio MM. Villoldo GM, et al. Among authors: barrio mm. Oncol Res. 2023 Apr 10;31(2):207-220. doi: 10.32604/or.2023.028163. eCollection 2023. Oncol Res. 2023. PMID: 37304240 Free PMC article.
Phenotypic and functional analysis in HER2+ targeted therapy of human NK cell subpopulation according to the expression of FcεRIγ and NKG2C in breast cancer patients.
Bordignon MB, Pesce Viglietti AI, Juliá EP, Sanchez MB, Rölle A, Mandó P, Sabatini L, Ostinelli A, Rizzo MM, Barrio MM, Mordoh J, Fainboim L, Levy EM. Bordignon MB, et al. Among authors: barrio mm. Cancer Immunol Immunother. 2023 Aug;72(8):2687-2700. doi: 10.1007/s00262-023-03448-w. Epub 2023 Apr 21. Cancer Immunol Immunother. 2023. PMID: 37081323 Free PMC article.
An Update of Cutaneous Melanoma Patients Treated in Adjuvancy With the Allogeneic Melanoma Vaccine VACCIMEL and Presentation of a Selected Case Report With In-Transit Metastases.
Mordoh A, Aris M, Carri I, Bravo AI, Podaza E, Pardo JCT, Cueto GR, Barrio MM, Mordoh J. Mordoh A, et al. Among authors: barrio mm. Front Immunol. 2022 Apr 1;13:842555. doi: 10.3389/fimmu.2022.842555. eCollection 2022. Front Immunol. 2022. PMID: 35432383 Free PMC article. Clinical Trial.
48 results